30 Years of Evidence

Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.

Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma

Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P | Pract Radiat Oncol | 2015

Malignant pleural mesothelioma – Pleural cavity irradiation after decortication with helical tomotherapy

Harrabi SB, Koerber SA, Adeberg S, Katayama S, Herfarth K, Debus J, Sterzing F | Rep Pract Oncol Radiother | 2017

Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma

Hong JH, Lee HC, Choi KH, Moon SW, Kim KS, Hong SH, Hong JY, Kim YS | Radiat Oncol J | 2019

Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer

Vekens K, Verbanck S, Collen C, Storme G, Barbé K, De Ridder M, Vanderhelst E | Strahlenther Onkol | 2020

Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation

Orecchia R, Rojas DP, Cattani F, Ricotti R, Santoro L, Morra A, Cambria R, Luraschi R, Dicuonzo S, Ronchi S, Surgo A, Dell’ Acqua V, Veronesi P, De Lorenzi F, Fodor C, Leonardi MC, Jereczek-Fossa BA | Med Oncol | 2018

Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment

Thery L, Arsene-Henry A, Carroll S, Peurien D, Bazire L, Robilliard M, Fourquet A, Kirova YM | Br J Radiol | 2018

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy-a single center experience

Arsene-Henry A, Foy JP, Robilliard M, Xu HP, Bazire L, Peurien D, Poortmans P, Fourquet A, Kirova YM | Oncotarget | 2018

Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients

Chitapanarux I, Nobnop W, Tippanya D, Sripan P, Chakrabandhu S, Klunklin P, Onchan W, Jia-Mahasap B, Tharavichitkul E | PLoS One | 2019

Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer

Mathieu D, Bedwani S, Mascolo-Fortin J, Côté N, Bernard AA, Roberge D, Yassa M, Bahig H, Vu T | Cureus | 2020

Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial

Joseph K, Vos LJ, Gabos Z, Pervez N, Chafe S, Tankel K, Warkentin H, Ghosh S, Amanie J, Powell K, Polkosnik LA, Horsman S, MacKenzie M, Sabri S, Parliament MB, Mackey J, Abdulkarim B | Clin Oncol (R Coll Radiol) | 2020

Prospective Study of Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer

Bataille B, Raoudha B, Le Tinier F, Basson L, Escande A, Langin H, Tresch E, Crop F, Darloy F, Carlier D, Lartigau E, Pasquier D | Cancers (Basel) | 2020

Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial

de Paula U, D’Angelillo RM, Andrulli AD, Apicella G, Caruso C, Ghini C, Gomellini S, Ponti E, Pompei M, Caccavari A, Petrocchi A, Costarelli L, Giordano M, La Pinta M, Meli EZ, Mauri M, Minelli M, Rossi R, Scavina P, Broglia L, Ponzani T, Loreti A, Fortunato L | Int J Radiat Oncol Biol Phys | 2021

Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer

Van Parijs H, Vinh-Hung V, Fontaine C, Storme G, Verschraegen C, Nguyen DM, Adriaenssens N, Nguyen NP, Gorobets O, De Ridder M | BMC Cancer | 2021

The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons

Leonardi MC, Kouloura A, Rojas DP, Zaffaroni M, Intra M, Veronesi P, Morra A, Gerardi MA, Fodor CI, Zerella MA, Camarda AM, Cattani F, Luraschi R, Viola A, Riva G, Miglietta E, Orecchia R, Dicuonzo S, Jereczek-Fossa BA | Br J Radiol | 2021

Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience

Zolcsak Z, Loap P, Fourquet A, and Kirova YM | Cancer Radiother | 2022

Excellent Outcomes With Stereotactic Body Radiotherapy in an Elderly Patient With Locally Progressive Immunotherapy-Resistant Renal Cell Carcinoma

Miriam Torrisi, Laura Giannini, Roberta Tummineri, Chiara Lucrezia Deantoni, Andrei Fodor | Cureus Competition | 2025

Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer: The Georgetown University Experience

Vaibhav Sharma, Tim Kearney, Zach Lee, Padraig Brennan Pilkington, Marielle Fis Loperena, Malika Danner, Alan L. Zwart, Deepak Kumar, Brian Collins, Michael Carrasquilla, Suy Simeng, Sean Collins | Cureus Competition | 2025

Investigation of the Response of Binary Multileaf Collimator Compensation to Target Setup Errors in the Radixact Synchrony System: A Phantom Study

Masatoshi Miura, Koji Sasaki, Yasuo Shiota, Kazuyasu Inoue | Cureus Competition | 2025

TomoTherapy With Synchrony Fiducial Tracking for Stereotactic Body Radiotherapy in Prostate Cancer: A Single-Center Experience on Toxicity

Lorella Lo Conte Jr., Vincenzo Iorio, Ida Rosalia Scognamiglio, Antonio Russo, Ersilia Donda, Alfonsina Pepe, Anna Viggiano, Ferdinando Francomacaro, Ivona Zlatkova, Caterina Muto. | Cureus Competition | 2025